We really need to hear some good news with all tha
Post# of 36536
(Total Views: 314)
Posted On: 09/04/2020 10:20:20 AM
We really need to hear some good news with all that is going on.
With the Illiad fiasco now that has just happened, with another S-1/A being put in, there needs to be something that Generex / NGIO can hang their hats on.
One of the big hightlights for NGIO was the money that NGIO had with Illiad, and the S-1 hasn't even been put in yet for NGIO, yet we are still waiting for the Form 10A to be approved by the SEC. When is that going to happen and now, when will the S-1 be put in and how does all of this all impact that now that Illiad is under investigation?
I'm sorry, but how many deals does Joe and Generex make that goes bad percentage wise? How many successes has he had? How many timelines has he missed? What are we waiting on that still needs to be delivered that is keeping us from being successful?
We are all waiting on just one thing to be successful that will push Generex / NGIO forward and they can't even get out of the starting gate because of missteps, bad deals, SEC documents written bad, not answered, not approved, or when they get funding.
The products and potential are there. What the heck is actually the problem here?
With the Illiad fiasco now that has just happened, with another S-1/A being put in, there needs to be something that Generex / NGIO can hang their hats on.
One of the big hightlights for NGIO was the money that NGIO had with Illiad, and the S-1 hasn't even been put in yet for NGIO, yet we are still waiting for the Form 10A to be approved by the SEC. When is that going to happen and now, when will the S-1 be put in and how does all of this all impact that now that Illiad is under investigation?
I'm sorry, but how many deals does Joe and Generex make that goes bad percentage wise? How many successes has he had? How many timelines has he missed? What are we waiting on that still needs to be delivered that is keeping us from being successful?
We are all waiting on just one thing to be successful that will push Generex / NGIO forward and they can't even get out of the starting gate because of missteps, bad deals, SEC documents written bad, not answered, not approved, or when they get funding.
The products and potential are there. What the heck is actually the problem here?
(5)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼